Wegovy savings card
Novo Nordisk publishes this at As little as $25 a month. Copay card — needs insurance that already covers the drug.
Last updated 2026-08-19 — the last time this offer was read from Novo Nordisk's own page
What does the Wegovy savings card actually get you?
Novo Nordisk publishes the Wegovy savings card at As little as $25 a month It is a copay card rather than a price: it lowers what you pay at the counter only where insurance is already covering most of the cost, and the manufacturer caps its own contribution, so with no coverage it does close to nothing. The condition attached: Savings are capped at $100 a month, so it only reaches $25 if your plan already covers most of the cost. It cannot be used with Medicare or Medicaid at all: federal anti-kickback rules bar a manufacturer from subsidising a copay inside a federal programme. Without any programme, halfrx records Wegovy at $349 a month at the maintenance dose, verified against the seller's own page on 2026-08-19. A pharmacy acquires it for about $1,306 a month under the federal NADAC survey, which is the number every offer here is worth reading beside.
The terms, as published
- Price
- As little as $25 a month
- Who for
- Commercial insurance that covers Wegovy. Government beneficiaries excluded.
- The catch
- Savings are capped at $100 a month, so it only reaches $25 if your plan already covers most of the cost.
- Ends
- No published end date
- Source
- www.novocare.com/patient/medicines/wegovy/savings-offer.htmlread 2026-08-19
If your plan already covers Wegovy
This is the case the Wegovy savings card is built for. The plan pays the bulk, the card pays down what is left of the copay up to the sponsor's own cap, and the published figure is what a covered patient sees at the counter. What you pay still counts towards your deductible and out-of-pocket maximum, because it is a copay — that is the structural advantage over any cash price.
If it does not cover Wegovy
The Wegovy savings card does close to nothing here. A copay card reduces a copay; with no coverage there is no copay, and the sponsor's cap means the card cannot bridge a full list price. This is the point at which most coupon pages stop being useful. The cash route for Wegovy is Wegovy first-fill price. Getting the plan to cover it is the other route, and it is worth trying before settling for a cash price.
What Wegovy costs with no programme at all
halfrx records $349 a month at the maintenance dose, read from the seller's own page on 2026-08-19. That is the figure the Wegovy savings card has to beat to be worth the conditions attached to it.
A pharmacy acquires Wegovy for about $1,306 a month under the federal NADAC survey, effective 2026-06-16. Where a sponsor's cash price sits below that, it is not a discount off the pharmacy channel — it is a different market with no intermediary to pay.
A first year is not twelve times the advertised month. Walking the titration ladder at each step's published price gives $4,237 rather than the $4,188 the monthly figure implies. One month is one box of four weekly pens, so a year is 13 fills rather than 12. The full Wegovy ladder prices every step.
The other programme for Wegovy
- Wegovy first-fill price
$199 a month for 0.25 mg and 0.5 mg — self-pay price — the figure with insurance out of the picture.
Questions about the Wegovy savings card
- Do I need insurance to use the Wegovy savings card?
- Yes, and not merely insurance — a commercial plan that already covers Wegovy. The card pays down a copay that exists; where the plan covers nothing there is no copay to reduce, and the card does close to nothing. Novo Nordisk also excludes anyone on Medicare, Medicaid or any other federal programme.
- What is the catch on the Wegovy savings card?
- Savings are capped at $100 a month, so it only reaches $25 if your plan already covers most of the cost.
- When does the Wegovy savings card end?
- No end date is published. That is not the same as permanent — an offer withdrawn quietly is the failure mode this page exists to catch, which is why the date it was last read sits beside every figure.
halfrx is not affiliated with Novo Nordisk and is paid nothing for listing this. Every figure is read from the sponsor's own page on the date shown. Information only, not medical advice.